Recall: D-0560-2022
Class II - Potentially Harmful
Class IIClassification
2022-01-14Initiated
TerminatedStatus
Aurobindo Pharma USA Inc.Firm
Product
Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03
Reason
Failed Impurities/Degradation Specifications
Distribution
USA Nationwide
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.